Corcept Therapeutics’ Post

We have seen this for years and the challenges associated with optimal management. I appreciate this research and data.

#type1diabetes is an autoimmune disease in which a person’s own immune system attacks the insulin producing cells. One cannot live without this vital hormone and patients have to administer insulin using pens and pumps. Diamyd Medical try to make a difference for those newly diagnosed with Type 1 Diabetes. Check the recruiting #precisionmedicine phase III clinical trial DIAGNODE-3 at diagnode-3.com 💙 #T1D #Diabetes

Investigators have implemented an automated health maintenance tool, created by the National Kidney Foundation, into electronic medical records, to hasten the screening of chronic kidney disease in adult patients with type 2 diabetes by primary care physicians. This innovative clinical decision support tool automatically offers a one-click option for ordering crucial kidney disease screening tests, such as the urine-albumin-to-creatinine ratio (UACR) or plasmatic creatinine. The impact of this resource was evident in the University of Virginia Health System, demonstrating significantly higher rates of UACR testing during primary care encounters and surpassing groups not using similar automated tools. This achievement may represent a significant leap forward in proactive kidney disease diagnosis. Read more, here: https://lnkd.in/e4DhZMpm #Diaverum #ExpertCare #Truecare #CKD #Dialysis #MedicalResearch

📚 The Ultimate Type 2 Diabetes Masterclass: 10 Questions, 20 Papers, Endless Possibilities! Embark on a transformative journey with this groundbreaking guide. Uncover the 10 most crucial questions and evidence-based answers every patient should know, supported by a wealth of medical research, including 20 papers and over 70 citations. Unlock the secrets to better glycemic control, reduced complications, and an improved quality of life. 👉 https://bit.ly/3UhQzgD #DiabetesManagement #HealthEducation #EvidenceBasedKnowledge

𝗜𝘁'𝘀 𝗧𝗵𝗿𝗼𝘄𝗯𝗮𝗰𝗸 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆! Let's take a look at a history of diabetes treatments. Since the discovery of insulin in 1921, science has advanced the medical treatment of Type 1 and Type 2 Diabetes as illustrated in the infographic. If you were a scientist, what would you invent to advance the treatment of diabetes? Let's brainstorm some great treatment ideas! List your ideas below --- dream big! #DiabetesTreatment #Type2DiabetesTreatment #SyntheticHumanInsulin

𝗜𝘁'𝘀 𝗧𝗵𝗿𝗼𝘄𝗯𝗮𝗰𝗸 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆! Let's take a look at a history of diabetes treatments. Since the discovery of insulin in 1921, science has advanced the medical treatment of Type 1 and Type 2 Diabetes as illustrated in the infographic. If you were a scientist, what would you invent to advance the treatment of diabetes? Let's brainstorm some great treatment ideas! List your ideas below --- dream big! #DiabetesTreatment #Type2DiabetesTreatment #SyntheticHumanInsulin

🌟🩸 Navigating the Future: Tirzepatide emerges as a revolutionary approach in managing #Type2Diabetes! 🔄💙 Type 2 diabetes is a chronic metabolic condition characterized by insulin resistance and impaired insulin secretion. Type 2 diabetes affects millions of people worldwide, posing a significant challenge for patients and healthcare providers alike. In the world of diabetes, the quest for more effective treatments and breakthroughs in medical research remains persistent. One exciting discovery is tirzepatide, a new kind of medicine for type 2 diabetes. Going beyond conventional approaches, it brings forth a new era of treatment, blending efficacy with a focus on overall well-being. For more details read our blog @ https://lnkd.in/gVm_BcVA and know more about type 2 diabetes, #TirzepatideInnovation #DiabetesCareRevolution #HealthForward #FutureOfHealthcare #WorldDiabetesDay #Type2DiabetesSymptoms #Type2DiabetesDiet #Type1DiabetesDiet #Type2DiabetesTreatment #SignsOfType2Diabetes #TypeTwoDiabetesSymptoms #Tirzepatide #ChroniMetabolicCondition #GlucoseDependentInsulinotropicPolypeptide #ClincalTrails #Bhimar #LifeSciences #Healthcare #Informations #Omics

In a study published in Endocrine Practice, researchers suggest that initiating continuous glucose monitor use in the emergency department benefits diabetes patients with limited access to long-term care. The University of Massachusetts Chan Medical School found greater A1c reduction with CGM, especially in newly diagnosed cases, indicating its feasibility and potential in engaging difficult-to-reach patients. While the pilot study faced recruitment challenges, over 90% of participants and providers found CGM useful in this setting. #CGMs #freestylelibre #diabetescare #diabetestype1 #diabetesmanagement

📚 The Ultimate Type 2 Diabetes Masterclass: 10 Questions, 20 Papers, Endless Possibilities! Embark on a transformative journey with this groundbreaking guide. Uncover the 10 most crucial questions and evidence-based answers every patient should know, supported by a wealth of medical research, including 20 papers and over 70 citations. Unlock the secrets to better glycemic control, reduced complications, and an improved quality of life. 👉 https://bit.ly/3UhQzgD #DiabetesManagement #HealthEducation #EvidenceBasedKnowledge